Advertisement
News
Subscribe to MDT Magazine News

Replacement execution drug ample, but has issues

March 2, 2011 10:45 am | by GREG BLUESTEIN - Associated Press - Associated Press | Comments

The drug that states are increasingly counting on to replace a sedative used in executions shares several drawbacks with the one that's no longer readily available.But there's one key difference: Experts say there's plenty of the replacement — a drug called pentobarbital. And it's not likely...

Fighting cancer at your local Indian restaurant

March 2, 2011 10:38 am | by EurekAlert | Comments

(American Friends of Tel Aviv University) Dr. Shahar Lev-Ari of the Sackler Faculty of Medicine at Tel Aviv University has found that curcumin, an ingredient found in turmeric -- a bright yellow spice from south Asia and the main ingredient in curries -- can fight cancer when used...

TOPICS:

Insulet signs insulin device distribution deal with GSK

March 2, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Bedford-based medical device maker Insulet Corp. has signed an exclusive distribution agreement with GlaxoSmithKline Inc. in Canada. The deal relates to Insulet's OmniPod Insulin Management System.

Advertisement

New NeuroPhage funding to back move to Alzheimer's trial

March 2, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

NeuroPhage Pharmaceuticals Inc., which closed a $12.4M Series B round Tuesday, said that it plans to use the funds to get its lead compound to treat Alzheimer's disease, NPT001, into a Phase 1 clinical trial in about a year and a half.

$3.6 million research project underway to reduce mother and baby deaths in Malawi

March 2, 2011 8:37 am | by EurekAlert | Comments

(University of Warwick) Warwick Medical School has just begun a ?2.6 ($3.6) million three year research and training program to train Malawian clinical officers in a bid to reduce the country's high death rate for pregnant mothers and babies.

TOPICS:

Accretive Health 4th-quarter profit surges

March 2, 2011 7:45 am | by The Associated Press | Comments

Accretive Health Inc., which helps hospital systems manage their revenue cycles, said Wednesday its fourth-quarter profit more than doubled on higher services revenue.Accretive said its net income rose to $5.5 million, or 6 cents per share, up from $2.3 million, or 5 cents per share, during the...

FDA CONSUMER HEALTH INFORMATION - FDA Intends to Remove Unapproved Drugs From Market

March 2, 2011 7:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 2, 2011 /PRNewswire-USNewswire/ -- Do you use a prescription cough, cold, or allergy relief drug? (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Federal regulators aim to take certain unapproved prescription medicines intended to relieve cough, cold,...

TOPICS:

FDA Prompts Removal of Unapproved Drugs From Market

March 2, 2011 6:39 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 2, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, or market certain unapproved prescription oral cough, cold, and allergy products. The affected products cannot be legally...

TOPICS:
Advertisement

Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government

March 2, 2011 6:36 am | by Bio-Medicine.Org | Comments

EAST SETAUKET, N.Y., March 2, 2011 /- Lixte Biotechnology Holdings (OTC: LIXT) announced today that the company has received a $244,479.25 grant under the Qualifying Therapeutic Discovery Project (QTDP).  This grant was awarded to further development and commercialization of Lixte's...

TOPICS:

Ikaria® to Present at 31st Annual Cowen and Company Healthcare Conference

March 2, 2011 6:35 am | by Bio-Medicine.Org | Comments

CLINTON, N.J., March 2, 2011 /- Ikaria, Inc. today announced that its Chairman and CEO, Daniel Tasse, will present at the 31st Annual Cowen and Company Healthcare Conference on Wednesday, March 9, 2011 at 8:30 a.m. EST.  The conference will be held March 7-9 at the Boston Marriott...

TOPICS:

Unapproved Cough, Cold, Allergy Products: FDA Prompts Removal From Market

March 2, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

Unapproved products have not been evaluated by the FDA for safety, effectiveness, and quality.

TOPICS:

Proton Pump Inhibitor drugs (PPIs): Drug Safety Communication - Low Magnesium Levels Can Be Associated With Long-Term Use

March 2, 2011 5:30 am | by U.S. Food & Drug Administration | Comments

Prolonged treatment with prescription PPIs may lead to low serum magnesium levels, which can result in serious adverse events including muscle spasm (tetany), irregular heartbeat (arrhythmias), and convulsions (seizures).

TOPICS:

e-MDs Continues Track Record of Employee and Revenue Growth

March 2, 2011 4:36 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, March 2, 2011 /- e-MDs, a leading provider of electronic health records (EHRs), is proud to announce another year of record revenue and employee growth.  In 2010 e-MDs doubled their growth rate from the previous two years.  Total employee count grew from 209 to...

TOPICS:

Naviscan Announces European Launch of Positron Emission Mammography

March 2, 2011 4:35 am | by Bio-Medicine.Org | Comments

VIENNA, March 2, 2011 /- Naviscan, Inc., announces the European launch of the Naviscan Positron Emission Mammography (PEM) scanner at two prestigious radiology conferences in Vienna.  On March 3rd, at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting, a podium...

TOPICS:

PositiveID Corporation Reaches Important Chemistry Milestone in Development of Its GlucoChip(TM) Glucose-Sensing Microchip

March 2, 2011 4:33 am | by PositiveID | Comments

PositiveID Corporation Reaches Important Chemistry Milestone in Development of Its GlucoChip(TM) Glucose-Sensing Microchip

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading